Dublin-based Medtronic plc received U.S. FDA approval for an expanded indication for its Pipeline Flex embolization device. The new indication allows options for patients with small or medium, wide-necked brain aneurysms in the territory from the petrous to the terminus of the internal carotid artery (ICA).